Literature DB >> 6963

Markedly elevated angiotensin converting enzyme in lymph nodes containing non-necrotizing granulomas in sarcoidosis.

E Silverstein, J Friedland, H A Lyons, A Gourin.   

Abstract

Sarcoidosis is a disease of unknown etiology that is characterized by the generalized formation of granulomas and is accompanied by elevation in the serum in less than half the patients of angiotensin converting enzyme, a dipeptidyl carboxypeptidase that catalyzes the conversion of the decapeptide, angiotensin I, to the pressor octapeptide, angiotensin II, and L-histidyl-L-leucine. Mean activity of angiotensin converting enzyme was elevated generally more than 10-fold in granuloma-containing lymph nodes, but not in lung in which normally it is abundant, in 19 of 20 patients with sarcoidosis. Angiotensin converting enzyme in lymph nodes from subjects with sarcoidosis was similar to the enzyme from normal lung and lymph node with respect to activity as a function of pH, inhibition of activity by EDTA and o-phenanthroline, gel filtration on Sephadex G-200, and requirement for chloride for activity, but appeared to be more heat labile. The data suggest that the granulomas in sarcoidosis may be the source of the elevated serum enzyme and that cells of the granulomas, particularly the epitheloid cells which appear by electron microscopy to have active protein biosynthesis, may be actively synthesizing the enzyme.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 6963      PMCID: PMC430465          DOI: 10.1073/pnas.73.6.2137

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Editorial: Modern concepts of sarcoidosis.

Authors:  D G James
Journal:  Chest       Date:  1973-12       Impact factor: 9.410

2.  Membrane-bound angiotensin-converting enzyme from rat lung.

Authors:  J J Lanzillo; B L Fanburg
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

3.  Studies on antibody surveillance to EB virus-induced antigen in patients with sarcoidosis and nasopharyngeal carcinoma by indirect immunofluorescence.

Authors:  M Naito; Y Akiyama; S Kato; T Tachibana; T Sakai
Journal:  Biken J       Date:  1973-12

4.  Concentrations of angiotensin-converting enzyme in tissues of the rat.

Authors:  D W Cushman; H S Cheung
Journal:  Biochim Biophys Acta       Date:  1971-10

5.  Antibodies to various herpesviruses in sera from patients with sarcoidosis.

Authors:  B Wahren; E Carlens; A Espmark; H Lundbeck; S Löfgren; E Madar; G Henle; W Henle
Journal:  J Natl Cancer Inst       Date:  1971-10       Impact factor: 13.506

6.  Sarcoidosis, another disease associated with serologic evidence for herpes-like virus infection.

Authors:  Y Hirshaut; P Glade; B D Vieira; E Ainbender; B Dvorak; L E Siltzbach
Journal:  N Engl J Med       Date:  1970-09-03       Impact factor: 91.245

7.  On enzyme histochemistry of sarcoidosis.

Authors:  T Palva; K Dammert; A Palva
Journal:  Acta Pathol Microbiol Scand A       Date:  1973-03

8.  Lymphocyte response in sarcoidosis.

Authors:  M Topilsky; L E Siltzbach; M Williams; P R Glade
Journal:  Lancet       Date:  1972-01-15       Impact factor: 79.321

9.  A transmissible agent from sarcoid tissue.

Authors:  D N Mitchell; R J Rees
Journal:  Lancet       Date:  1969-07-12       Impact factor: 79.321

10.  Fine structure and histochemistry of epithelioid cells in sarcoidosis.

Authors:  E M James; W J Williams
Journal:  Thorax       Date:  1974-01       Impact factor: 9.139

View more
  18 in total

1.  Sarcoidosis and mononuclear phagocytes.

Authors:  J B Gee; P T Bodel; S K Zorn; L M Hinman; C A Stevens; R A Matthay
Journal:  Lung       Date:  1978       Impact factor: 2.584

2.  The angiotensin converting enzyme in pulmonary sarcoidosis and the relative diagnostic value of serum lysozyme.

Authors:  S K Zorn; C A Stevens; E N Schachter; J B Gee
Journal:  Lung       Date:  1980       Impact factor: 2.584

Review 3.  Sarcoidosis causing duodenal obstruction. Case report and review of gastrointestinal manifestations.

Authors:  D A Stampfl; I S Grimm; D J Barbot; F E Rosato; S J Gordon
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

4.  Converting enzyme activity of free airway cells.

Authors:  P Sirois; A Cadieux
Journal:  Inflammation       Date:  1986-09       Impact factor: 4.092

5.  In vitro synthesis of angiotensin-converting enzyme by alveolar macrophages is increased in disseminated sarcoidosis.

Authors:  G Stanislas-Leguern; M Mordelet-Dambrine; D Dusser; M Huesca; J Chretien; G J Huchon
Journal:  Lung       Date:  1986       Impact factor: 2.584

Review 6.  Serum angiotensin converting enzyme in pulmonary disease.

Authors:  P K Rohatgi
Journal:  Lung       Date:  1982       Impact factor: 2.584

7.  Changes of s-angiotensin-converting enzyme (SACE) during antituberculous chemotherapy.

Authors:  H Harving; F K Rømer
Journal:  Lung       Date:  1983       Impact factor: 2.584

8.  Lack of correlation between serum angiotensin-converting enzyme levels and asbestosis in man, sheep and guinea-pig.

Authors:  G Forget; C Brault; A Cadieux; R Bégin; P Sirois
Journal:  Lung       Date:  1983       Impact factor: 2.584

9.  Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas.

Authors:  E Silverstein; L P Pertschuk; J Friedland
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

10.  Human lung angiotensin converting enzyme. Purification and antibody preparation.

Authors:  J Friedland; E Silverstein; M Drooker; C Setton
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.